HK1224376A1 - 用於分離外來體的方法和組合物 - Google Patents

用於分離外來體的方法和組合物

Info

Publication number
HK1224376A1
HK1224376A1 HK16112680.2A HK16112680A HK1224376A1 HK 1224376 A1 HK1224376 A1 HK 1224376A1 HK 16112680 A HK16112680 A HK 16112680A HK 1224376 A1 HK1224376 A1 HK 1224376A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
isolating exosomes
exosomes
isolating
Prior art date
Application number
HK16112680.2A
Other languages
English (en)
Inventor
.施洛特
.特洛佩
.富希
Original Assignee
Univ Texas
Peregrine Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Peregrine Pharmaceuticals Inc filed Critical Univ Texas
Publication of HK1224376A1 publication Critical patent/HK1224376A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
HK16112680.2A 2014-02-27 2016-11-03 用於分離外來體的方法和組合物 HK1224376A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461945718P 2014-02-27 2014-02-27
US201461970529P 2014-03-26 2014-03-26
PCT/US2015/018183 WO2015131153A1 (en) 2014-02-27 2015-02-27 Methods and compositions for isolating exosomes

Publications (1)

Publication Number Publication Date
HK1224376A1 true HK1224376A1 (zh) 2017-08-18

Family

ID=52630541

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112680.2A HK1224376A1 (zh) 2014-02-27 2016-11-03 用於分離外來體的方法和組合物

Country Status (12)

Country Link
US (1) US9835626B2 (zh)
EP (1) EP3111212B1 (zh)
JP (1) JP6156962B2 (zh)
KR (1) KR101738117B1 (zh)
CN (1) CN106030304B (zh)
AU (1) AU2015222755B2 (zh)
CA (1) CA2940823C (zh)
HK (1) HK1224376A1 (zh)
IL (1) IL247413A (zh)
NZ (1) NZ723336A (zh)
SG (1) SG11201606702SA (zh)
WO (1) WO2015131153A1 (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016276750A1 (en) 2015-06-09 2018-01-18 The Board Of Regents Of The University Of Texas System Diagnostic test for early stage cancer
WO2017136430A1 (en) 2016-02-01 2017-08-10 The Board Of Trustees Of The Leland Stanford Junior University Exosome-total-isoloation-chip (exotic) device for isolation of exosome-based biomarkers
WO2017141947A1 (ja) * 2016-02-15 2017-08-24 凸版印刷株式会社 エクソソーム複合体の形成方法
JP6853983B2 (ja) * 2016-04-04 2021-04-07 国立研究開発法人産業技術総合研究所 生物物理学的解析に適した膜小胞の調製方法
JP2019518428A (ja) * 2016-04-12 2019-07-04 ユニシテ エーファウ アクチェンゲゼルシャフト 体液試料からの細胞外小胞(ev)の単離
SG11201809649WA (en) 2016-05-02 2018-11-29 Encodia Inc Macromolecule analysis employing nucleic acid encoding
WO2018064013A1 (en) 2016-09-27 2018-04-05 Peregrine Pharmaceuticals, Inc. METHODS FOR TREATING CANCER WITH BAVITUXIMAB BASED ON LEVELS OF β2-GLYCOPROTEIN 1, AND ASSAYS THEREFOR
KR20200020662A (ko) 2017-04-03 2020-02-26 온콜로지, 인크. 면역-종양학 제제와 함께 ps-표적화 항체를 사용하여 암을 치료하는 방법
KR101895916B1 (ko) 2017-08-11 2018-09-07 주식회사 엑소코바이오 엑소좀 및/또는 세포외 소포체 및 이를 포함하는 조성물의 제조 방법
WO2019083201A2 (ko) * 2017-10-24 2019-05-02 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 신장 기능 개선 용도
AU2018358057B2 (en) 2017-10-31 2023-03-02 Encodia, Inc. Kits for analysis using nucleic acid encoding and/or label
KR20190070227A (ko) 2017-12-12 2019-06-20 주식회사 엑소코바이오 엑소좀 및/또는 세포외 소포체의 기능적 활성을 평가하는 방법
KR102077643B1 (ko) 2018-02-09 2020-04-07 광운대학교 산학협력단 메니스커스 곡면을 갖는 시료 내 입자 분리 장치 및 방법
KR102130023B1 (ko) 2019-02-18 2020-07-03 고려대학교 산학협력단 엑소좀을 분리하기 위한 다중 컬럼 및 엑소좀 분리 방법
KR101980482B1 (ko) 2018-02-20 2019-05-20 고려대학교 산학협력단 엑소좀을 분리하기 위한 다중 컬럼 및 엑소좀 분리 방법
US20200378932A1 (en) 2018-02-20 2020-12-03 Korea University Research And Business Foundation Multi-column for isolating exosomes and exosome isolation method
GB201809622D0 (en) * 2018-06-12 2018-07-25 Evox Therapeutics Ltd Engineering extracellular vesicles for affinity purification
CN110604813A (zh) * 2018-06-14 2019-12-24 深圳市人民医院 一种肿瘤细胞来源外泌体抗原在dc疫苗中的应用方法
US20230026916A1 (en) * 2018-07-05 2023-01-26 Active Genomes Expressed Diagnostics, Inc Viral Oncogene Influences and Gene Expression Patterns as Indicators of Early Tumorigenesis
US11510876B2 (en) 2019-03-29 2022-11-29 Mayo Foundation For Medical Education And Research In vivo targeting of extracellular vesicles
MX2021012886A (es) * 2019-04-25 2022-01-04 Flagship Pioneering Innovations Vi Llc Composiciones y metodos relacionados con paquetes mensajeros de plantas.
CN114072499A (zh) 2019-04-30 2022-02-18 Encodia 公司 用于制备分析物的方法和相关试剂盒
CN112048462B (zh) * 2019-06-05 2022-08-23 北京丰特云基科技发展有限公司 一种基于阴离子多聚物修饰基质的细胞外囊泡分离富集方法
WO2021040999A1 (en) * 2019-08-27 2021-03-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Methods and compositions for stimulating exosome secretion
JPWO2021132213A1 (zh) * 2019-12-23 2021-07-01
WO2021142088A1 (en) * 2020-01-07 2021-07-15 The Trustees Of The University Of Pennsylvania Source specific exosomes for determining avoidance of cancer treatment and avoidance of checkpoint inhibitor therapies
WO2021146326A2 (en) * 2020-01-14 2021-07-22 Pure Protein Llc Hla peptide ligands from the plasma exosome
KR102184428B1 (ko) * 2020-05-25 2020-11-30 주식회사 씨케이엑소젠 중배엽줄기세포 유래의 엑소좀 생산방법 및 이로부터 제조된 배양액
WO2022145980A1 (ko) 2020-12-29 2022-07-07 주식회사 한국유니온 생명과학 고효율 및 고순도의 엑소좀 분리방법
WO2022146083A1 (ko) * 2020-12-30 2022-07-07 한국과학기술원 엑소좀 분리용 조성물 및 이를 이용한 엑소좀 분리 방법
CN112831457A (zh) * 2021-02-07 2021-05-25 辽宁润基生物科技有限公司 一种分离和浓缩外泌体的方法
CN112920988B (zh) * 2021-02-07 2022-12-06 广州四叶草健康科技有限公司 一种毛乳头细胞外泌体制备分离方法
KR20220164446A (ko) 2021-06-04 2022-12-13 기초과학연구원 염 분별 침전을 이용한 세포외 소포체 분리 방법
CN115125238B (zh) * 2022-07-23 2023-11-14 新乡学院 一种肿瘤细胞外囊泡dna的分离纯化方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7262167B2 (en) 1995-11-06 2007-08-28 Exibona Ltd. Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites
US20020102208A1 (en) * 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
US7790159B2 (en) 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
CA2623429C (en) * 2005-09-30 2015-01-13 Medimmune Limited Interleukin-13 antibody composition
DK3517151T3 (da) 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
EP2613149B1 (en) * 2007-07-25 2014-09-17 University Of Louisville Research Foundation, Inc. Exosome-associated microRNA as a diagnostic marker
US20130052647A1 (en) 2010-02-10 2013-02-28 Marianna Goldrick Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery
WO2012087241A1 (en) * 2010-12-20 2012-06-28 Agency For Science, Technology And Research Method of purifying exosomes
US8530228B2 (en) 2010-12-28 2013-09-10 Bexmart Integrated versatile and systems preparation of specimens
US20130273544A1 (en) 2012-04-17 2013-10-17 Life Technologies Corporation Methods and compositions for exosome isolation
US9005888B2 (en) 2012-06-14 2015-04-14 System Biosciences, Llc Methods for microvesicle isolation and selective removal
KR101933621B1 (ko) 2012-09-28 2018-12-28 삼성전자주식회사 소포를 분리하기 위한 조성물, 키트 및 이를 이용하여 소포를 분리하는 방법

Also Published As

Publication number Publication date
US20150241431A1 (en) 2015-08-27
US9835626B2 (en) 2017-12-05
KR20160115988A (ko) 2016-10-06
AU2015222755A1 (en) 2016-09-08
EP3111212A1 (en) 2017-01-04
IL247413A (en) 2017-01-31
JP6156962B2 (ja) 2017-07-05
JP2017509332A (ja) 2017-04-06
WO2015131153A1 (en) 2015-09-03
KR101738117B1 (ko) 2017-05-19
CA2940823A1 (en) 2015-09-03
AU2015222755B2 (en) 2016-12-15
CN106030304A (zh) 2016-10-12
EP3111212B1 (en) 2018-08-29
NZ723336A (en) 2017-04-28
CA2940823C (en) 2017-03-28
CN106030304B (zh) 2018-02-06
SG11201606702SA (en) 2016-09-29

Similar Documents

Publication Publication Date Title
HK1224376A1 (zh) 用於分離外來體的方法和組合物
IL285565B (en) Methods and preparations for immune modulation
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
IL249011B (en) Methods and preparations related to exosomes
GB2535253B (en) Compositions and methods
IL253341B (en) Methods and preparations for combined immunotherapy
GB2546350B (en) Compositions and methods
HK1249174A1 (zh) 用於捕獲外來體的組合物和方法
GB201718876D0 (en) Antithrombin-heparin compositions and methods
IL246879B (en) Preparations of Epilimod and methods of using them
GB201417828D0 (en) New methods and compositions
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
HK1254822A1 (zh) 用於減少tau表現之組合物及方法
IL249226A0 (en) Methods and preparations for immune modulation
ZA201607571B (en) Compositions and methods for detecting huanglongbing
SG11201701402QA (en) Anti-tumor compositions and methods
EP3097420A4 (en) Methods and compositions for immune dis-inhibition
PL3223846T3 (pl) Kompozycje adiuwantowe i powiązane sposoby
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
IL248513B (en) Preparations and methods for immunomodulation against lyst
GB201512996D0 (en) Compositions and methods
GB201514413D0 (en) Compositions and methods
PT3160263T (pt) Composições para prevenção de infeções
GB201402915D0 (en) Compositions and methods
IL256261B (en) Hide1 compositions and methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220227